Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by educational grants from Gilead Sciences, Inc., Novartis Pharmaceuticals Corporation, and Takeda Oncology.

Exploring Current and Emerging Data Sets to Move Treatment of Higher-Risk MDS Forward: A Focus on Novel Targets and Treatment Approaches.

Release Date: June 16, 2021
Expiration Date: June 16, 2022

Activity Overview

This educational activity is an archive of the live virtual presentation held on June 10, 2021.

For more information about this educational activity, please click here.
 

Acknowledgement of Commercial Support

This activity is supported by educational grants from Gilead Sciences, Inc., Novartis Pharmaceuticals Corporation, and Takeda Oncology.


Learning Objectives

Upon successful completion of this activity, you should be better prepared to:
  • Explain the criteria for MDS diagnosis, and guidelines for risk stratification among these patients
  • Determine the impact of risk assessment on treatment selection in patients with higher-risk MDS
  • Assess the efficacy and safety profiles for current and emerging agents/combinations in patients with higher-risk MDS
  • Evaluate updated clinical evidence from landmark trials in the context of current treatment algorithms for patients with higher-risk MDS

Co-Chairs

Mikkael A. Sekeres, MD
Mikkael A. Sekeres, MD
Chief, Division of Hematology
Sylvester Comprehensive Cancer Center
University of Miami Health System
Miami, FL


 
Amy DeZern, MD, MHS
Amy DeZern, MD, MHS
Director, Bone Marrow Failure and MDS Program
Associate Professor of Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD


 
Rami S. Komrokji, MD
Rami S. Komrokji, MD
Senior Member
Section Head, Leukemia and MDS
Vice Chair, Department of Malignant Hematology
Moffitt Cancer Center
Professor of Medicine and Oncologic Sciences
University of South Florida
Tampa, FL
 
Bhumika Patel, MD
Bhumika Patel, MD
Member, Hematopoietic and Immune Cancer Biology Program Case Comprehensive Cancer Center
Case Western Reserve University
Cleveland Clinic
Cleveland, OH


 

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

 

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Related CME Activites
Exploring Current and Emerging Data Sets to Move Treatment of Higher-Risk MDS Forward: A Focus on Novel Targets and Treatment Approaches
Exploring Current and Emerging Data Sets to Move Treatment of Higher-Risk MDS Forward: A Focus on Novel Targets and Treatment Approaches
Expires on July 20, 2022
Mikkael A. Sekeres, MD; Amy DeZern, MD, MHS; Rami S. Komrokji, MD; Bhumika Patel, MD
CME
2.0
Show Me the Data<sup>®</sup>: Managing Clinical Challenges in Advanced EGFR Mutation–Positive NSCLC
Show Me the Data®: Managing Clinical Challenges in Advanced EGFR Mutation–Positive NSCLC
Expires on July 8, 2022
David R. Gandara, MD; Heather M,Wakelee, MD; Edward B.Garon, MD, MS; Lecia C.Sequist, MD, MPH; Collin Blakely MD, PhD
CME
2.0
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
 123456
78910111213
14151617181920
21222324252627
282930
Filter By